User:Tuuli Lahti

Contact Info


Tuuli Lahti

Senior researcher, National Institute for Health and Welfare, Department of Mental Health and Substance Abuse services, Helsinki, Finland

Adjunct Professor of Neurophysiology, Faculty of Social Sciences, Department of Behavioural Sciences and Philosophy, University of Turku, Finland

e-mail: tuuli.lahti(at)gmail.com
 * Email me through OpenWetWare

Education
December 2008, Ph.D, University of Helsinki, Faculty of Biological and Environmental Sciences 

Major: Neurophysiology

Minors: Philosophy, Social Psychology

February 2008, MS.c, University of Helsinki, Faculty of Biological and Environmental Sciences 

Major: Neurophysiology

Minors: Genetics, Microbiology

Publications
Research articles and reviews in English:
 * 1) Pallanti S, Lahti T. Transcultural studies of OCD: towards a neuroscientific approach. In press/Psychiatria Fennica 2011.
 * 2) Lahti T, Methuen T, Roine R, Seppä K, Sinclair D, Partinen M and Alho H. The impacts of nitrous oxide gas on sleep quality during alcohol withdrawal. BMC Research Notes 2011;4:108.
 * 3) Lahti T, Halme J, Pankakoski M, Sinclair D, Alho H. Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot study. Psychopharmacological Bulletin 2010;43:35-44.
 * 4) Lahti T, Sysi-Aho J, Haukka J, Partonen T. Work related accidents and daylight saving time in Finland. Occupational Medicine 2011, 61:26-8.
 * 5) Lahti T, Leppämäki S, Tani P, Partonen T. Effect of sustained-release methylphenidate on sleep and circadian rest-activity cycles in adult patients with Attention Deficit-Hyperactivity Disorder. Psychiatria Fennica 2010;188-199.
 * 6) Lahti T, Nysten E, Haukka J, Sulander P, Partonen T. Daylight Saving Time Transitions and Road Traffic Accidents. Journal of Environmental and Public Health 2010, 657167:1-3
 * 7) Lahti T, Leppamaki S, Tani P, Partonen T. Actigraphic recording of manic symptoms induced by methylphenidate. Case Report Med. 2009;286430.
 * 8) Lahti T, Leppämäki S, Partonen T. Sleep deprivation in the treatment of mood disorder. Psychiatria Fennica 2009;51-60.
 * 9) Lahti TA, Partonen T. CREM mutations and ADHD symptoms. Med.Hypotheses 2009;72:544-545.
 * 10) Lahti TA, Partonen T, Kyyronen P, Kauppinen T, Pukkala E. Night-time work predisposes to non-Hodgkin lymphoma. Int.J.Cancer 2008;123:2148-2151.
 * 11) Lahti TA, Haukka J, Lonnqvist J, Partonen T. Daylight saving time transitions and hospital treatments due to accidents or manic episodes. BMC Public Health 2008;8:74.
 * 12) Lahti TA, Leppamaki S, Lonnqvist J, Partonen T. Transitions into and out of daylight saving time compromise sleep and the rest-activity cycles. BMC Physiol. 2008;8:3.
 * 13) Lahti T, Leppämäki S, Partonen T. Effects of paroxetine on the daily rest-activity cycles and sleep quality in patients with seasonal affective disorder: a randomized placebo-controlled trial. Psychiatria Fennica 2008;85-88.
 * 14) Lahti T, Terttunen J, Leppamaki S, Lonnqvist J, Partonen T. Field trial of timed bright light exposure for jet lag among airline cabin crew. Int.J.Circumpolar Health 2007;66:365-369.
 * 15) Lahti TA, Leppamaki S, Lonnqvist J, Partonen T. Transition to daylight saving time reduces sleep duration plus sleep efficiency of the deprived sleep. Neurosci.Lett. 2006;406:174-177.
 * 16) Lahti TA, Leppamaki S, Ojanen SM, Haukka J, Tuulio-Henriksson A, Lonnqvist J, Partonen T. Transition into daylight saving time influences the fragmentation of the rest-activity cycle. J.Circadian Rhythms 2006;4:1.

Research articles and reviews in Finnish:
 * 1) Lahti T. Peliriippuvaisilla on havaittu muutoksia useiden eri hermovälittäjäainejärjestelmien toiminnassa. Erikoislääkäri 2011;1:15-17.
 * 2) Merikanto I, Partonen T, Lahti T. Evoluution säilyttämä uni. Duodecim 2011;127:57-64.
 * 3) Lahti T, Sihvonen E, Partonen T. Suojaako oikeaan aikaan aloitettu lääkehoito ADHD-potilaita päihdehäiriöiltä? Erikoislääkäri 2009;1:11-13.
 * 4) Lahti T, Leppämäki S, Tani P, Partonen T. Aikuisten ylivilkkaus-tarkkaavuushäiriön lääkehoito. Suomen lääkärilehti 2008;8:741-744.
 * 5) Lahti T, Partonen T. Sairaudet muuttavat vilkeunta. Duodecim 2007;123:1065-1070.
 * 6) Niinimäki H, Heikkinen T, Kujanpää A, Kurling S, Lahti T, Valkeapää S, Hirsjärvi P, Saunanoja S, Siitonen A. Asiallisuutta ja avoimuutta eläinkoekeskusteluun. Suomen lääkärilehti 2005;12-13:1452 (in Finnish).

Other publications:
 * 1) World Health Organization. Global status report on alcohol and health 2011. (participated as an International Expert), 2011;1-298.
 * 2) Lahti T, Alho H. Voittajana kotiin: hoito-ohjelma naltreksonin käyttäjille (in Finnish). Publications of the National Institute for Health and Welfare, 2010;1-31.
 * 3) World Health Organization. mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings. Mental Health Gap Action Programme, Version 1.0. (participated as an International Expert), 2010;1-121.
 * 4) Lahti T. Circadian rhythm disruptions and health (Ph.D. thesis). Publications of the National Public Health Institute, 2008;21:1-60.
 * 5) Lahti T. Metyylifenidaatin vaikutukset aikuisten ADHD-potilaiden unen laatuun, vuorokausirytmiin ja melatoniinin eritykseen (M.Sc. thesis, in Finnish). Pro gradu - work, University of Helsinki 2007;1-50.

Employment history
Present employer

National Institute for Health and Welfare, 01/09 -present

Senior researcher: Clinical and epidemiological research in the Department of Mental Health and Substance Abuse Services

The most important previous employments

National Public Health Institute, 06/05-12/08

Researcher: Clinical and epidemiological research in the Department of Mental Health and Alcohol Research

Åbo Akademi, 05/04-08/04

Research assistant: Department of Pharmacy and Biochemistry

Pedagogical experience
Vantaa technical college Varia, 02/08-04/08

Teacher: Physiology and anatomy

Training Team Eximia, 03/04-05/05

Teacher: Physiology and biology

Training centre Metafor, 03/04-04/04

Author: Physiology instruction material for pharmacy students

International collaboration and conferences
Boston, USA, Harvard Medical School, Division on Addictions, 06/11-09/11

Research collaboration on pathological gambling.

Florence, Italy, Instituto di Neuroscienze and Carreggi hospital, 06/10-08/10

Writing review-articles about Obsessive-Compulsive Disorder and Impulsivity in collaboration with Professor S.Pallanti.

Auckland, New-Zealand, 02/10

International conference, Gambling in the 21st Century – the Implications of Technology for Policy, Practice and Research.

Macau, China, 12/09

International Conference on the Gaming Industry and Public Welfare.

Geneva, Switzerland, World Health Organization, 06/08-08/08 & 06/09 - 08/09

Revising the following reports: Global Status Report on Alcohol and Health 2010; Recommended indicators for monitoring consumption, harm, treatment and policy responses of alcohol and substance abuse; mhGAP intervention guide.

Glasgow, Great-Britain, 09/08

19th Congress of the European Sleep Research Society.

Scientific confidential posts and affiliations
International College of Obsessive Compulsive Spectrum Disorders, 2010 - present

Membership

Finnish society of addiction medicine, 2009 - present

Membership

Finnish Union of University Researchers and Teachers, 2008 - present

Membership

Finnish Federation of University Women, 2008 - present

Membership

Neuroscience center, University of Helsinki, 2005-2008

Member of the Board

Finnish Sleep Research Society, 2005 - present

Membership

Faculty council of the faculty of Biological and Environmental Sciences, University of Helsinki, 2004-2008

Member of the Board

Useful links

 * Introductory tutorial
 * OpenWetWare help pages